Jyong Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Debt / Equity Ratio	-0.49	-0.49	-0.48	-0.51
Debt / EBITDA Ratio	-4.69	-4.69	-2.48	-3.63
Debt / FCF Ratio	-6.44	-6.44	-4.43	-5.56
Quick Ratio	0.12	0.12	0.18	0.38
Interest Coverage	-5.28	-5.28	-7.72	-4.06
Return on Equity (ROE)	12.91%	12.91%	22.38%	18.00%
Return on Assets (ROA)	-53.35%	-53.35%	-75.81%	-44.51%
Return on Capital (ROIC)	16.14%	16.14%	18.39%	20.84%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).